For Dr. Karen Gibbins, a maternal-fetal medicine specialist at Oregon Health & Science University, her son’s death in her 27th week of pregnancy sparked questions only an autopsy could answer.
For-profit companies can exploit the way Medicare has designed the hospice benefit, which rewards providers for recruiting patients who aren’t imminently dying.
UnitedHealth, which has been expanding in Oregon, is under scrutiny over issues that include its data practices.
Every year more than 20,000 pregnancies in the U.S. result in a stillbirth, but not all of these tragedies were inevitable.
More than a year after Biden’s executive order to promote competition, the FTC's oversight of hospital consolidation may be stronger in rhetoric than in reality.
State and federal missteps amplified long-standing health inequities when it comes to testing and treatment of Monkeypox.
Facing a drop in supply, two global companies are suing over a U.S-imposed ban on Mexicans entering the country selling their blood.
Michal Freedhoff, the new director of the Office of Chemical Safety and Pollution Prevention, has a long history as a toxics watchdog. Can she succeed?
A year after President Joe Biden signed an order creating an entity modeled on FDR’s hugely successful Wartime Production Board, to be called the Pandemic Testing Board, there’s little trace of it.